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A B S T R A C T
Background: Studies evaluating the role of long-term exposure to fine particulate matter (PM2.5) on chronic
obstructive pulmonary disease (COPD) development showed inconsistent results and were limited to Western
countries. We aimed to determine the association between long-term exposure to PM2.5 and COPD development
in metropolitan cities in Korea, which have higher PM2.5 levels than those in Western country studies.
Methods: We constructed a retrospective cohort (elderly aged over 65 years who resided in 7 metropolitan cities
in 2008) using Korea health insurance data. A total of 687,940 elderlies who had not visited hospitals due to
COPD for 3 years (from 2008 to 2010) were followed-up from 2011 to 2016. The first hospital visit due to COPD
during the follow-up period was regarded as COPD development. Daily district-level PM2.5 concentrations were
estimated by chemical transport model and 60-month moving average PM2.5 were assigned to each subject in
time-varying Cox proportional hazard model.
Results: The mean concentration of modelled PM2.5 in 7 metropolitan cities during the study period (from 2006
to 2016) was 28.0 μg/m3 and 259,700 subjects newly visited the hospital due to COPD. COPD hospital visit
hazard ratio for a 10 μg/m3 increase in 60-month moving average PM2.5 concentration was 1.09 (95% con-
fidence interval: 1.07, 1.11). Risks remained unchanged following different PM2.5 exposure levels (48-month
moving average, and average PM2.5 concentrations for 2008 and 2008–2010) and in subgroup analysis by
subject characteristics (sex, age, and income groups).
Discussion: By following-up 687,940 elderly subjects who resided in metropolitan cities in Korea for 6 years,
long-term PM2.5 exposure showed association with COPD development.
1. Introduction
Chronic obstructive pulmonary disease (COPD) is a respiratory
disease characterized by airflow limitation and disruption of lung par-
enchyma with progressively worsening cough and breathlessness
(Pauwels et al. 2001). Although the major risk factor is cigarette
smoking, environmental factors such as household and ambient air
pollution exposure and occupational dust and chemical exposure are
believed to play a considerable role in disease pathogenesis (Pauwels
et al. 2001; Salvi and Barnes 2009). For example, household air
pollutants arising from the use of solid fuels may cause inflammation
and oxidative stress to the bronchial epithelium and lung parenchyma,
which leads to airway obstruction and disruption of the lung par-
enchyma (Silva et al. 2015). Recent meta-analysis has shown an in-
creased risk of COPD and chronic bronchitis among household solid fuel
users (Kurmi et al. 2010). Several intervention studies in developing
countries showed improved chronic respiratory symptoms after redu-
cing household air pollution levels, suggesting a close association be-
tween household air pollution and COPD development (Gordon et al.
2014).
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Although the overall exposure levels, toxicities, and types of pol-
lutants differ from those of household air pollution, several cohort
studies in the U.S. and Canada showed increased COPD and respiratory
mortality after long-term exposure to ambient air pollution (Lepeule
et al. 2012; Lipsett et al. 2011; Pinault et al. 2017). Based on the study
results, the World Health Organization (WHO) estimated that globally
over 76,500 COPD deaths were attributable to ambient particulate
matter less than 2.5 μm in diameter (PM2.5) exposure, in 2016 (World
Health Organization 2018). Based on the Global Burden of Disease es-
timates, 27.1% of COPD mortality in the world were attributable to
ambient PM2.5 exposure in 2015 (Cohen et al. 2017).
However, most of the previous ambient air pollution and COPD
studies focused on mortality instead of intermediate health outcomes
such as hospital admission or ambulatory care. Although few studies
reported the long-term effects of PM2.5 on the initiation of COPD by
using hospital admission records, the results were inconsistent
(Andersen et al. 2011; Atkinson et al. 2015; Gan et al. 2013; Guo et al.
2018). In addition, most of the previous studies were conducted in the
Western countries where annual PM2.5 concentrations are below the
WHO guideline value of 10 μg/m3. Therefore, evidences regarding the
effects of long-term exposure to ambient air pollution on COPD devel-
opment are still limited and inconclusive, especially in high PM2.5
concentration ranges.
Therefore, we evaluated the association between long-term ex-
posure to PM2.5 and COPD development in elderly population in Korea,
where PM2.5 levels are higher than those in Western countries. Due to
the high incidence rate of COPD among aged population, we focused on
the elderly aged over 65 years in our study. By constructing a popula-
tion cohort based on Korea health insurance data, we were able to se-
cure the largest number of elderly subjects compared to previous stu-
dies.
2. Methods
2.1. Study design and population
The present study constructed a retrospective cohort based on the
data from the National Health Insurance Database (NHID) in Korea.
Due to the single-payer health insurance system, the NHID archives all
the hospital service information including the date of hospital use,
primary and secondary diagnostic codes (International Classification of
Disease, 10th revision code), and procedures and medication use during
the hospital service for almost the entire Korean population (over 97%).
The database also contains the yearly characteristics of the insurance
policy holder or dependents including age, sex, household income, and
district-level residential information. A detailed explanation of NHID
was published previously (Seong et al. 2016). Based on the researchers’
requests, the National Health Insurance Service (NHIS) customizes the
NHID (customized dataset) and provides to the researchers.
We designed our dataset focusing on the elderly population residing
in 7 metropolitan cities (Seoul, Busan, Daegu, Incheon, Gwangju,
Daejeon, and Ulsan) in Korea with 3 years of wash-out period (from
2008 to 2010, to define previous COPD-related hospital use) and
6 years of follow-up period (from 2011 to 2016, to define COPD de-
velopment) (Fig. 1). Due to the data provision policy of NHIS regarding
the size of the customized data, we could only obtain hospital use data
for elderly subjects residing in metropolitan cities in Korea for limited
disease outcome (COPD) and time period (for the years 2008 to 2016).
Among the entire elderly population who were aged over 65 years
in 2008 (n = 1,720,230), we restricted our study subjects to those who:
1) maintained the NHIS qualification during the study period; 2) was
still alive during the wash-out period; 3) had lived in a metropolitan
city in year 2008, and 4) had maintained the same address during the
study period 2008–2016. After further excluding subjects who used the
hospital due to COPD during the wash-out period (n = 328,076), we
followed-up 687,940 subjects with no prior history of COPD hospital
visits. Based on the district-level residential data of each subject, we
assigned PM2.5 exposure data to each subject. This study was exempted
from review by the Institutional Review Board of the Seoul National
University Hospital (E-1807-038-956) because we used de-identified
data provided by NHIS and had complied with the NHIS personal in-
formation protection guideline.
2.2. COPD hospital visits
We used the International Classification of Disease, 10th revision
codes to define hospital visits due to COPD (J40-J44). If subject’s pri-
mary or secondary diagnostic code for hospital visit was coded as
COPD, we regarded it as a COPD hospital visit case. We did not separate
the mode of visits (emergency or non-emergency), types of hospital
(primary or tertiary), and types of medical service (admission or am-
bulatory care) in the analysis to screen all the COPD related hospital
visits.
2.3. PM2.5 exposure data
The study subjects were assigned to district-level PM2.5 concentra-
tions based on their residential information in the NHID. We utilized
the Weather Research and Forecast (WRF, version 3.3.1) - Sparse Matrix
Operator Kernel Emission (SMOKE, version 3.1) - Community
Multiscale Air Quality (CMAQ, version 4.7.1) model to estimate me-
teorology, chemistry, and emission over Korea. This model enables
researchers to estimate short as well as long term PM2.5 trend in a
district-level. The details and validity of the PM2.5 modelling data are
summarized in previous papers (Kim et al., 2017a, 2017b). In brief, air
quality was simulated by CMAQ model (with AERO5 aerosol module)
and version 99 Statewide Air Pollution Research Center (Byun and
Schere 2006). Meteorology was simulated by using WRF with the Na-
tional Center for Environmental Protection Final data (Skamarock and
Klemp 2008). The meteorology was further processed with the Me-
teorology-Chemistry Interface Processor (MCIP, version 3.6) for CMAQ
modelling (Otte and Pleim 2010). Anthropogenic and biogenic emis-
sions were simulated by using the SMOKE processing Korean National
Emissions Inventory data (Clean Air Policy Support System 2010) and
by using the Model of Emissions of Gases and Aerosols from Nature
(MEGAN), respectively.
Two model domains, sized 27-km (covering northeast Asia) and 9-
km, were used in our analysis. The 27-km modelling domain simulation
results were used to estimate the boundary condition for the 9-km
domain. We first simulated the hourly concentration of PM2.5 at the
grid level and resampled the values to the district-level based on the GIS
shape file. By comparing modelled data with observation data from the
monitoring station (for year 2015 to 2016 when the monitoring data
were available), the correlation coefficient was over 0.95. We were
unable to use the monitoring data in our study because district-level
PM2.5 monitoring in metropolitan cities in Korea began in 2015.
The district level PM2.5 exposure levels were linked to each subject
as follows. First, the daily average PM2.5 levels in each district of me-
tropolitan cities were estimated using the chemical transport model.
Then, for each month during the follow-up period, the 60-month and
48-month moving average exposures of PM2.5 were calculated and as-
signed to each subject (Dekker et al. 2008). Although we have 6 years of
hospital use data from year 2011 to 2016, PM2.5 modelling data were
only available from year 2006. Therefore, the longest time period to
address the chronic effect of PM2.5 exposure was 5 years (60 months)
and we selected 48 months for the sensitivity analysis. In addition,
average exposure values for year 2008 and 2008 to 2009 based on the
residential address were calculated and assigned to each subject for the
sensitivity analysis using Cox proportional hazard models.
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2.4. Covariates
We extracted the following personal level data for the year 2008
from the customized dataset of NHID: age (years), sex (men or women),
and household income. The NHID provides household income on a
scale of 1 to 20 (1 being the lowest and 20 the highest). Based on this
income scales, we classified the household income into 4 groups (Q1,
1–5; Q2, 6–10; Q3, 11–15; Q4, 16–20). Contextual variables as used in
previous studies were selected to adjust for neighborhood and regional
effects on subjects’ health in our analysis model (Gan et al. 2013;
Pinault et al. 2017). We selected data for the district-level proportion of
subjects with high school diploma (%), proportion of current smokers
(%), monthly average income (1,000 KRW), and standardized mortality
rate (per 100,000 person). The data, nearest to 2008, the start year of
our study, were acquired from publically accessible database. Propor-
tion of current smokers in each district for year 2010 was acquired from
the Community Health Survey results while the proportion of subjects
with high school diploma and standardized mortality rate for year 2010
were acquired from Korea Statistical Information Service (Kang et al.
2015; Statistics Korea 2018). The monthly average income data for year
2016, which was the nearest data to that of 2008, were retrieved from
the National Pension Service (National Information Society Agency
2018). Descriptive statistics of district-level covariates in 7 me-
tropolitan cities are summarized in Table S1.
2.5. Statistical analysis
We constructed time-varying Cox proportional hazards models to
estimate the effects of chronic PM2.5 exposure on COPD hospital visits
(Dekker et al. 2008). The time-varying Cox proportional hazard model
enables researchers to estimate the effects of time-dependent risk fac-
tors (e.g. PM2.5) on health outcomes (e.g. COPD-related hospital visit).
In conventional survival analysis, we are estimating the chronic effects
of certain risk factors evaluated at a certain time point by assuming that
the risk factors do not change over time. However, the PM2.5 exposure
level assigned to each subject may change due to the long-term trends
and daily fluctuation of PM2.5 levels. To address this issue, the time-
varying Cox proportional hazard model used in our study calculates the
hazard ratio (HR) for moving average PM2.5 concentration in each
monthly time intervals and was weighted averaged to generate single
HR value.
The follow-up time (in months) was calculated from the start of the
follow-up period (January 2011) until the first COPD-related hospital
visit or death or the end of the study period (December 2016),
whichever came first. The 60- and 48-month moving average PM2.5
concentrations were assigned to each study subject in monthly intervals
during the follow-up period. The hazard ratios (HR) per 10 μg/m3 in-
crease in 60- and 48-month moving average PM2.5 were calculated. The
analysis model was stratified by sex and age (5 yearly intervals, 65–69,
70–74, 75–79, 80–84, and ≥ 85 years), thereby having own baseline
hazards and adjusted for personal- and contextual-level variables se-
lected a priori. In model 1, we adjusted for year 2008 household income
(4 groups) and residential region (metropolitan city). In model 2, we
further adjusted for district-level contextual variables: proportion of
subjects with high school diploma, proportion of current smokers,
monthly average income, and standardized mortality rate for each
district.
We conducted stratified analysis by sex, age group (65–69, 70–74,
Fig. 1. Flow chart for study population who met inclusion and exclusion criteria.
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75–79, 80–84, and ≥ 85 years), and income groups. The interaction
terms between PM2.5 concentration and baseline characteristics (sex,
age, and income groups) were constructed to evaluate for potential
effect modification in both model 1 and model 2. The ex-
posure–response curve between 60-month moving average exposure to
PM2.5 and COPD hospital visits was plotted using the natural cubic
splines (3 knots presented at 0.05, 0.50, 0.95 percentiles of PM2.5
concentration). We also constructed Cox proportional hazard models to
estimate the effects of baseline PM2.5 exposure levels on COPD devel-
opment, instead of using time-varying moving average PM2.5 exposure.
The year 2008 to 2010 and year 2008 average PM2.5 exposure levels
were assigned to each study subject. The stratification and covariates
used in the analysis were identical to the time-varying Cox proportional
hazards models.
A series of sensitivity analyses were conducted to evaluate the ro-
bustness of our study findings. First, we changed the study period by
increasing the wash-out period (from 2008 to 2013) and decreased the
follow-up period (from 2014 to 2016) to apply more strict criteria (no
prior COPD-related hospital visits occurred during the previous 6 years)
to define COPD incidence case. Secondly, we applied random effect of
metropolitan cities in multilevel time-dependent Cox model to see the
potential clustering effect by metropolitan city. Thirdly, we applied
different COPD hospital visit definitions by focusing on the primary
COPD diagnostic code or by regarding subjects with two or more COPD
hospital visits as a COPD development case. Last, we did not restrict the
study participants to those who maintained the same address and
therefore, included all the subjects who maintain the health insurance
qualification during the study period and conducted the analysis. All
the analyses were conducted with SAS version 9.4 (SAS Institute Inc.,
Cary, NC, USA) and R statistical software (version 3.6.1; R Foundation
for Statistical Computing, Vienna, Austria). The level of statistical sig-
nificance was set at a p-value of less than 0.05.
3. Results
The demographic characteristics of the study population are pre-
sented in Table 1 and Table S2. Among 687,940 subjects, 58% were
women, majority were aged 65–69 years, and belonged to the highest
income group. During the 6 years of follow-up, 259,700 subjects
(37.8%) were newly diagnosed with COPD and the overall average
follow-up time for all subjects was 50.1 months. Overall incidence rate
by metropolitan cities were from 34.6 (Daejeon) to 43.4% (Busan)
(Table S2).
The spatial and temporal yearly PM2.5 concentration trends in the
metropolitan cities in Korea are presented in Table 2. The mean con-
centration of the modelled PM2.5 in the 7 metropolitan cities during the
year 2006 to 2016 was 29.0 μg/m3 while the overall PM2.5 con-
centration was decreased in all metropolitan cities in Korea during the
period.
Table 3 shows the HR of COPD hospital visits for each 10 μg/m3
increase in PM2.5 exposure levels. After stratifying by age and sex; and
adjusted for household income groups, metropolitan city, and district-
level covariates, a 10 μg/m3 increase in 60-month moving average
PM2.5 was associated with an elevated risk of COPD hospital visits of
1.09 [95% confidence interval (CI): 1.07, 1.11]. By using year 2008 to
2010 average PM2.5 exposure levels, a 10 μg/m3 increase in PM2.5 was
associated with an elevated risk of COPD hospital visits of 1.07 [95%
CI: 1.05, 1.10]. The analysis with 48-month moving average and year
2008 baseline PM2.5 exposure showed similar results. The ex-
posure–response curve between 60-month moving average PM2.5 ex-
posure and risks of COPD hospital visits is presented in Fig. 2. The risk
of COPD hospital visits increased as PM2.5 exposure increased, showing
an increasing linear pattern after 30 μg/m3 concentration ranges. There
was no increase in risks at concentration ranging from 20 to 30 μg/m3.
In sex- and incomes-stratified group, effect estimates were slightly
higher in women (p-value for interaction: 0.16) and in the high income
group (p-value for interaction: 0.25) (Table S3 and S4). In age-stratified
group, the effect estimates increased continuously with increasing age,
but those aged 85 years or older showed null results (p-value for in-
teraction less than 0.01). In a sensitivity analysis with different wash-
out period, the random effect of metropolitan cities, and different COPD
definitions showed similar results with our main analysis results (Table
S5, S6, and S7). When we did not restrict the study participants to those
who maintained the same address, we found similar results to our main
analysis (Table S8).
When we changed our definition of COPD development to that of
subjects with two or more hospital visits due to COPD during the
follow-up period, 171,961 subjects (25.0%) were newly diagnosed with
COPD. We found similar results with the main analysis, showing that a
10 μg/m3 increase in 60-month moving average of PM2.5 was associated
with an elevated risk of COPD hospital visits of 1.11 [95% confidence
interval (CI): 1.08, 1.14] (Table S7).
4. Discussion
In our retrospective cohort study using Korea health insurance data,
long-term exposure to PM2.5 increased the risk of COPD development in
the elderly population. A 10 μg/m3 increase in 60-month moving
average PM2.5 was associated with a 9% increase in COPD hospital
visits. Stratification analysis by sex, age, and income groups; and di-
verse sensitivity analysis with different PM2.5 exposure levels, COPD
definitions, and study period showed consistent results. The linear ex-
posure–response relationship between PM2.5 and risk of COPD hospital
visits was observed in concentration ranges over 30 μg/m3.
One of the strengths of our study is the population based study
sample. In contrast to previous cohort studies evaluating chronic ex-
posure to air pollution and COPD mortality or COPD development using
convenient samples (Andersen et al. 2011; Lepeule et al. 2012; Lipsett
et al. 2011), we were able to perform an evaluation including almost all
the elderly who have resided in the metropolitan cities in Korea. By
using the diagnostic codes from the health insurance data, and focusing
on the elderly residing in metropolitan city with high quality medical
infrastructures, we were able to objectively define subjects with COPD.
In addition, limited daily activities as well as commutabilities of the
elderly add reliability to our PM2.5 exposure estimation, which were
estimated based on the district level residential data.
Chronic exposure to ambient PM2.5 is linked to mortality due to
ischemic heart disease, stroke, COPD, lung cancer, and acute re-
spiratory infection (Cohen et al. 2017). However, although air pollution
exposure may not lead to mortality, it may cause milder health com-
plications in a large number of people (Samet and Krewski 2007).
Therefore, studies focusing not only on mortality, but also on mor-
bidity, are needed to quantify the accurate health burden attributable to
ambient air pollution.
However, most of the previous ambient air pollution cohort studies
dealing with COPD focused on mortality, showing mainly positive, but
null associations were also observed in several studies. In an analysis of
7,805 subjects from the Harvard Six Cities study, a 10 μg/m3 increase in
PM2.5 was found to be associated with an elevated risk of COPD mor-
tality of 1.17 (95% CI: 0.85, 1.62) (Lepeule et al. 2012). Among 2.4
million persons from Canadian Census Health Environment Cohort, a
10 μg/m3 increase in PM2.5 was associated with an elevated risk of
COPD mortality of 1.24 (95% CI: 1.11, 1.39) (Pinault et al. 2017). In a
follow-up of over 100,000 subjects from the California Teachers Study,
a 10 μg/m3 increase in PM2.5 was associated with an elevated risk of
non-malignant respiratory mortality of 1.21 (95% CI: 0.97, 1.52)
(Lipsett et al. 2011). By following-up a population-wide sample of Oslo,
Norway residents for 6 years, increased risk of COPD mortality was
observed in subjects with the highest PM2.5 exposure (Næss et al. 2006).
In contrast, no association and inverse association, between PM2.5
exposure and COPD mortality were observed in several studies. In the
Cancer Prevention II study, a 10 μg/m3 increase in PM2.5 was associated
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with decreased risk of 0.84 (95% CI: 0.77, 0.93) for COPD and related
deaths (Pope III et al. 2004). In a cohort study of 63,520 subjects in
Japan, a 10 μg/m3 increase in PM2.5 was associated with decreased risk
of 0.84 (95% CI: 0.77, 0.93) for COPD mortality, but the number of
COPD deaths was very small (n = 64) (Katanoda et al. 2011). Null
association in previous mortality studies may be partly due to under-
diagnoses of COPD and different reporting patterns on the death cer-
tificates of each country (Schikowski et al. 2014). In particular, with
negative association between chronic exposure to PM2.5 and COPD, but
positive association with acute mortality outcomes such as pneumonia
or influenza in Cancer Prevention II study; supports the hypothesis that
COPD-related deaths may be coded as pneumonia or influenza deaths
(instead of as COPD), which are common end-stage acute disease in
COPD patients.
The studies evaluating the association between chronic exposure to
air pollution and COPD hospital visits showed inconsistent results. In an
analysis of 52,799 subjects from the Danish cohort, an interquartile
range increase in residential nitrogen dioxide and nitrogen oxides were
associated with an elevated risk of COPD incidence of 1.08 (95% CI:
1.02, 1.14) and 1.05 (1.01, 1.10), respectively (Andersen et al. 2011).
One cohort study of 812,063 patients from England found that an in-
terquartile range increase in baseline PM2.5 showed a risk of 0.97 (95%
CI: 0.71, 1.34) for the first general practitioner record of COPD, but an
elevated risk of 1.31 (95% CI: 0.92, 1.86) for the first COPD admission
(Atkinson et al. 2015). Among 467,994 subjects that resided in me-
tropolitan Vancouver, Canada, an interquartile range increase in black
carbon was associated with COPD hospitalization (RR: 1.06, 95% CI;
1.02, 1.10), but PM2.5 exposure showed null association (RR: 1.02, 95%
CI; 0.98, 1.07) (Gan et al. 2013). In a Taiwanese cohort study with
91,709 subjects, a 5 μg/m3 increase in PM2.5 was associated with ele-
vated risk of 1.08 (95% CI: 1.04, 1.11) for COPD development (Guo
et al. 2018). Compared to the lower PM2.5 concentration observed in
previous Western studies (mean PM2.5: 4.1 to 12.9 μg/m3), the Taiwan
cohort study involved relatively higher exposure level of PM2.5 (mean
Table 1
Descriptive statistics of the study subjects in year 2008 (n = 687,940).
Variable Total subject (n) Average PM2.5
(2008–2010),
Mean ± SE
(μg/m3)
Non-COPD cases, n (%) Average PM2.5
(2008–2010),
Mean ± SE
(μg/m3)
COPD cases, n (%) Average PM2.5
(2008–2010),
Mean ± SE
(μg/m3)
Total 687,940 31.2 ± 4.0 428,240 31.3 ± 4.0 259,700 31.0 ± 4.1
By sex
Men 292,170 31.3 ± 4.0 176,929 (41.3) 31.4 ± 4.0 115,241 (44.4) 31.1 ± 4.1
Women 395,770 31.2 ± 4.0 251,311 (58.7) 31.2 ± 4.0 144,459 (55.6) 31.0 ± 4.1
By age group
65–69 311,235 31.2 ± 4.0 185,001 (43.2) 31.4 ± 4.0 126,234 (48.6) 31.0 ± 4.2
70–74 197,218 31.2 ± 4.0 121,264 (28.3) 31.4 ± 4.0 75,954 (29.3) 31.0 ± 4.1
75–79 102,458 31.2 ± 4.0 66,183 (15.5) 31.3 ± 4.0 36,275 (14.0) 31.0 ± 4.1
80–84 50,125 31.1 ± 4.0 35,251 (8.2) 31.2 ± 4.0 14,874 (5.7) 31.1 ± 4.1
85- 26,904 31.3 ± 4.0 20,541 (4.8) 31.3 ± 4.0 6363 (2.5) 31.3 ± 4.0
By income group
Q1 (lowest) 104,844 31.4 ± 4.1 64,726 (15.1) 31.6 ± 4.1 40,118 (15.5) 31.2 ± 4.2
Q2 92,622 31.1 ± 4.2 57,530 (13.4) 31.2 ± 4.1 35,092 (13.5) 30.8 ± 4.3
Q3 157,753 31.1 ± 4.1 97,472 (22.8) 31.2 ± 4.1 60,281 (23.2) 30.9 ± 4.2
Q4 (highest) 332,721 31.3 ± 3.9 208,512 (48.7) 31.3 ± 3.9 124,209 (47.8) 31.0 ± 4.0
By metropolitan city
Seoul 306,295 34.2 ± 2.1 196,945 (46.0) 34.2 ± 2.1 109,350 (42.1) 34.3 ± 2.1
Busan 114,827 25.8 ± 1.9 65,047 (15.2) 25.8 ± 1.9 49,780 (19.2) 25.8 ± 1.9
Daegu 82,065 28.8 ± 1.3 51,199 (12.0) 28.9 ± 1.3 30,866 (11.9) 28.7 ± 1.3
Incheon 75,390 33.9 ± 3.7 47,319 (11.1) 33.7 ± 3.9 28,071 (10.8) 34.0 ± 3.5
Gwangju 41,379 28.0 ± 0.8 25,346 (6.0) 28.0 ± 0.8 16,033 (6.2) 28.0 ± 0.8
Daejeon 43,298 30.1 ± 0.2 28,321 (6.6) 30.1 ± 0.2 14,977 (5.8) 30.1 ± 0.2
Ulsan 24,686 26.4 ± 1.0 14,063 (3.3) 26.4 ± 1.0 10,623 (4.1) 26.4 ± 1.0
Contextual variables
Proportion of high school diploma (%) 67.62 ± 4.97 67.63 ± 5.04 67.44 ± 4.84
Proportion of current smokers (%) 24.7 ± 2.3 24.7 ± 2.3 24.8 ± 2.3
Monthly average income (1,000KRW) 1,301 ± 83.0 1,303 ± 84.1 1,298 ± 81.0
Standardized mortality rate per
100,000 persons
4584.7 ± 488.2 4577.0 ± 486.3 4597.4 ± 491.1
Table 2
Average PM2.5 concentration (mean ± SE, μg/m3) by year and metropolitan city.
Year Total Seoul Busan Daegu Incheon Gwangju Daejeon Ulsan
2006 34.3 ± 9.9 38.1 ± 12.0 30.1 ± 7.5 30.9 ± 8.5 38.4 ± 10.2 33.6 ± 11.9 33.3 ± 12.8 27.9 ± 9.4
2007 33.9 ± 9.1 38.5 ± 10.2 29.3 ± 7.4 30.2 ± 8.8 37.6 ± 10.5 29.4 ± 10.4 33.9 ± 12.3 28.2 ± 8.9
2008 31.1 ± 6.5 34.8 ± 6.3 25.8 ± 6.0 31.9 ± 7.8 32.5 ± 7.5 29.6 ± 9.2 30.4 ± 9.1 28.3 ± 6.9
2009 30.5 ± 6.7 35.4 ± 7.5 25.6 ± 5.9 26.6 ± 6.1 33.2 ± 7.6 27.9 ± 7.9 29.7 ± 8.7 25.7 ± 6.1
2010 29.3 ± 7.7 32.7 ± 8.6 25.4 ± 6.0 28.5 ± 7.8 30.8 ± 9.0 25.9 ± 9.1 30.0 ± 10.2 25.6 ± 6.0
2011 28.3 ± 7.5 30.9 ± 8.9 25.7 ± 5.9 26.4 ± 6.4 29.8 ± 7.9 24.3 ± 7.5 29.8 ± 10.3 25.3 ± 6.6
2012 25.3 ± 5.7 27.1 ± 6.6 23.9 ± 4.4 23.8 ± 5.2 26.3 ± 6.7 21.6 ± 6.1 26.2 ± 8.5 24.2 ± 4.6
2013 28.5 ± 7.1 31.8 ± 7.9 24.4 ± 6.0 27.0 ± 8.0 27.2 ± 7.0 26.9 ± 10.3 31.9 ± 10.8 28.1 ± 6.6
2014 27.6 ± 8.0 32.2 ± 9.6 24.1 ± 7.3 25.0 ± 7.8 28.9 ± 7.4 19.8 ± 7.0 27.7 ± 11.3 25.1 ± 8.1
2015 25.3 ± 4.5 24.2 ± 4.8 25.9 ± 5.2 24.9 ± 5.2 27.6 ± 5.2 24.1 ± 4.2 27.3 ± 6.7 24.6 ± 5.3
2016 25.4 ± 4.5 26.1 ± 4.3 26.9 ± 5.8 23.9 ± 3.9 25.5 ± 4.4 22.6 ± 4.1 24.7 ± 6.4 23.3 ± 4.2
Total 29.0 ± 7.6 32.0 ± 9.1 26.1 ± 6.2 27.2 ± 7.3 30.7 ± 8.6 26.0 ± 8.8 29.5 ± 9.9 26.0 ± 6.7
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PM2.5: 26.91 μg/m3), similar to the PM2.5 concentration observed in our
study [mean PM2.5 during the study period: 26.0 μg/m3 (Gwangju and
Ulsan, lowest) to 32.0 μg/m3 (Seoul, highest)].
However, as highlighted in a previous review paper, the overall
association between chronic exposure to air pollution and incidence of
COPD is still inconclusive (Schikowski et al. 2014). It was pointed out in
that previous paper that the use of hospital admission record may not
be able to properly capture the real COPD incidence because hospital
admission may incorporate acute exacerbation of previously diagnosed
COPD cases. Because previous studies in Denmark, Canada, and Eng-
land focused on hospital admission records only or partly, they were not
free from COPD incidence case ascertainment issue. In addition, dis-
tinguishing the chronic from acute effects of air pollution on COPD
development is challenging because short-term exposure to air pollu-
tion causes acute exacerbation of COPD, and short- and long-term ex-
posure are highly correlated (Schikowski et al. 2014).
To partially address the COPD incidence case ascertainment issue,
we did not separate the mode of visits, type of hospitals, and detailed
medical service use in the analysis to specify the subjects with no prior
history of COPD hospital visits, and to capture all COPD-related hospital
visits during the follow-up period. We also conducted sensitivity ana-
lysis by applying strict criteria (limiting the study subjects to persons
with no prior COPD-related hospital visits for 6 years; using primary
diagnostic codes to define COPD; defining the development of COPD as
two or more hospital visits with COPD diagnosis) to define COPD de-
velopment.
However, the ambiguous clinical course, with the slowly pro-
gressive nature of COPD, is challenging obstacles for the COPD case
ascertainment. For example, some patients with COPD have no obvious
clinical manifestations and can be diagnosed during a routine health
examination. Because populations with high socioeconomic status are
more likely to take health examinations, COPD patients can be more
and quickly diagnosed in high-income populations. In our study, al-
though the incidence rate of COPD hospital visits across income groups
was similar (37 ~ 38%), we observed an increasing trend of HR with
the increase of household income. This phenomenon may partially due
to an early diagnosis and screening of COPD in high socioeconomic
groups although p-value for interaction was not statistically significant.
Distinguishing the chronic from acute effects of air pollution is al-
ways a problem in air pollution studies and we may not be able to also
rule out the possibility that both chronic and acute effects of air pol-
lution on COPD hospital visits were incorporated in our study estimates.
Additional studies using repeated spirometer measurements as well as
hospital medical records with long duration of follow-up are needed.
The exposure–response curve between 60-month moving average
PM2.5 exposure and COPD hospital visits in our study is very similar to
that of a previous Taiwanese study. In the previous study, increasing
linear patterns of COPD incidence risks were observed at high PM2.5
exposure ranges over 35 μg/m3, although the risks were null between
20 and 35 μg/m3 exposure range (Guo et al. 2018). Similar pattern was
observed in our study showing increasing linear pattern at high ex-
posure of over 30 μg/m3, but no significant increase at PM2.5 con-
centration exposure level between 20 and 30 μg/m3 (Fig. 2). In con-
trast, PM2.5 exposure and COPD mortality exposure–response curves in
the Global Burden of Disease study and in a recent meta-analysis on air
pollution cohort studies showed increasing linear patterns of COPD risk
with increase in PM2.5 concentration, for the entire PM2.5 ranges
(Burnett et al. 2018; Cohen et al. 2017). However, we were unable to
determine the exposure–response curve in the lower ranges due to the
high levels of PM2.5 exposure in Korea.
Our study had several limitations. First, we were unable to adjust for
personal level characteristics such as smoking, drinking, and exercise.
Among diverse risk factors, smoking is the most important risk factor
for COPD development. However, because our cohort was constructed
based on health insurance claim data, we were unable to gather de-
tailed personal level information. Although we used district level cov-
ariates to adjust for neighborhood and regional effects on subjects’
health, further studies with better assessment of personal characteristics
are needed to confirm our study findings. For instance, the proportion
of current smokers in our study districts was around 25%, which makes
it difficult to completely eliminate the effects of primary and second-
hand smoking on COPD-related hospital visits without detailed per-
sonal level data. Therefore, additional stratification analyses and as-
sessment of the exposure–response curves by baseline characteristics
including smoking status are needed.
Secondly, we were unable to address previous hospital use data to
evaluate other co-morbidities in our study subjects. Subjects with un-
derlying chronic diseases may be more susceptible to long-term PM2.5
exposure (Wang et al. 2017). However, we were unable to obtain access
to data on other disease outcomes besides COPD in our analysis, due to
NHIS data provision policy and the personal information protection act.
In addition, although we evaluated data on all the elderly population
aged over 65 years who resided in metropolitan cities in Korea, the
elderly, residing in rural areas, were omitted in our study. Additional
sensitivity analyses by excluding subjects with previous history of other
Table 3
Hazard ratios (HR) for chronic obstructive pulmonary disease hospital visits for
10 μg/m3 increases in PM2.5 exposure.
Model 1 a) Model 2 b)
No. HR 95% CI HR 95% CI
60 month moving average
exposure
259700/
687940
1.10 1.08, 1.12 1.09 1.07, 1.11
48 month moving average
exposure
1.10 1.08, 1.12 1.10 1.07, 1.12
Year 2008–2010 baseline
exposure
1.08 1.06, 1.10 1.07 1.05, 1.10
Year 2008 baseline
exposure
1.08 1.06, 1.10 1.07 1.04, 1.09
a) Model 1: Stratified by age group and sex and adjusted for income group
and metropolitan city
b) Model 2: Stratified by age group and sex and adjusted for income group,
metropolitan city, and district-level proportion of high school diploma (%),
proportion of current smokers (%), monthly average income (1,000 KRW), and
standardized mortality rate (per 100,000 person)
Fig. 2. Hazard ratio plot for chronic obstructive pulmonary disease hospital
visits and 60-month moving average exposure to PM2.5.
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chronic diseases as well as studies in rural areas are required in the
future. Thirdly, because we used modelled district-level ambient PM2.5
concentration as the exposure of interest, the effect of household PM2.5
concentration was ignored in our study. Because most of the study
subjects were elderly people who may have longer indoor time activity
patterns, our exposure levels may not properly capture the individual
level exposure to PM2.5. Future studies with household PM2.5 mea-
surement are needed to estimate the association between personal level
chronic exposure to PM2.5 and development of COPD. In addition, other
air pollutants such as sulphur dioxide, black carbon, and nitric dioxide
that have been shown to be associated with COPD hospital visits could
not be evaluated in this study since the air pollution data was not
available at district level resolution. Fourth, the diagnostic accuracy of
COPD in health insurance data has not been evaluated. Although we
used several definitions of COPD using diagnostic codes; and our study
was conducted in metropolitan cities in Korea where medical quality
has reached a certain level, such misclassification may have shifted our
results toward the null.
By following 687,940 elderly subjects residing metropolitan cities in
Korea for 6 years, we found that long-term PM2.5 exposure was asso-
ciated with the development of COPD. A 10 μg/m3 increase in 60-
month moving average PM2.5 was associated with 9% increase in COPD
development. Additional studies using repeated spirometer measure-
ments as well as hospital medical records are needed to confirm our
study findings.
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